COSMO Pharmaceuticals SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares COSMO Pharmaceuticals SA with three other
pharmaceutical manufacturers in Europe:
Eco Animal Health Group Plc
of the United Kingdom
sales of £61.42 million [US$79.05 million]
of which 100%
was Animal Health Product),
(336.90 million Romanian Leu [US$82.31 million]
based in Sweden
(643.70 million Swedish Kronor [US$71.46 million]
of which 75%
COSMO Pharmaceuticals SA reported sales of 67.24 million Euro (US$76.59 million)
December of 2017.
decrease of 0.6%
versus 2016, when the company's sales were 67.66 million Euro.
Contributing to the drop in overall sales was the 32.8% decline
in Related Services, from 1.07 million Euro to 722,000.00 Euro.
There were also decreases in sales in
Manufacturing of Generic Products and Sp (down 9.7% to 8.26 million Euro)
Royalties (down 10.6% to 18.07 million Euro)
Other Revenues From Sale (down 12.5% to 805,000.00 Euro)
However, these declines were partially offset by the increase in sales of
Manufacturing of Mmx Products (up 1.2% to 36.32 million Euro)
License Fees and Milestones (up 237.1% to 1.50 million Euro)